We also support he bespoke stem
cell engineering team, which does not rely on LIMS systems so much owing of the nature of their work.
Not exact matches
Brendan Frey, CEO of Deep Genomics and a biomedical
engineering professor at the University of Toronto, says his research
team trained its system to analyze individual
cells to draw conclusions about the entire cellular system and, ultimately, make a diagnosis.
To see whether this also applies to humans, the
team engineered stem
cells from people with and without Down's syndrome and injected them into mice.
In an amazing feat of tissue
engineering, Anthony Atala and his research
team at the Children's Hospital in Boston are creating new organs in the laboratory using patients» own
cells and by employing the same technology used to clone Dolly the sheep.
The
engineered cells will circulate and, the
team hopes, home in on the cancer, says Lu.
The
team genetically
engineered immune
cells so that a calcium gate - controlling protein became light sensitive.
To determine the effect of mutations that reduce TET2 function in abnormal stem
cells, the research
team genetically
engineered mice such that the scientists could switch the TET2 gene on or off.
When G - CSF activates its receptor, it ultimately activates proteins called STATs; the
team engineered the
cells to churn out the light - generating protein luciferase, which would be turned on by the STAT molecules.
To speed the search, the
team had
engineered a line of mouse
cells to test for G - CSF - like activity.
The
cells are held within a millimeter - scale table - top microbioreactor, containing a microfluidic chip, which was originally developed by Rajeev Ram, a professor of electrical
engineering at MIT, and his
team, and then commercialized by Kevin Lee — an MIT graduate and co-author — through a spin - off company.
So Welham's
team set out to
engineer vocal fold mucosae in the lab using the two main
cell types that make up the tissue — connective fibroblasts, which form the main body, and epithelial
cells, which line the surface.
The goal of the multi-institutional
team is to develop genome
engineering - based methods for correcting the disease - causing mutation in each patient's own stem
cells to ensure that new red blood
cells are healthy.
To deliver the healthy gene, the
team inserted it into an
engineered virus called adeno - associated virus 1, or AAV1, together with a promoter — a genetic sequence that turns the gene on only in certain sensory
cells of the inner ear known as hair
cells.
Once Katlyn arrived in May 2007, Candotti and his
team removed stem
cells from her bone marrow and exposed them to the
engineered retrovirus, creating a human - virus hybrid.
In addition to using normal breast cancer
cells in the experiments, the
team also used cancer
cells that had been genetically
engineered to lack either GSTO1 or RYR1.
To
engineer an APC - mimetic scaffold, the
team first loaded tiny mesoporous silica rods (MSRs) with Interleukin 2 (IL - 2)-- an APC - produced factor that prolongs the survival of associated T
cells.
While
teams used a variety of
engineering strategies to enhance their
cells» chemotactic ability, the most successful
cells were an adapted version of Dicty with increased activity of a particular protein, Ric8, that enhanced G - protein signaling, helping chemotaxis in shallow chemical gradients.
June's
team also wants to knock out two gene segments that encode different portions of the protein that makes up a T
cell's primary receptor so that the
engineered NS - ESO - 1 receptor will be more effective.
The
team of medical and
engineering researchers at The Ohio State University previously determined that modifying a single gene to reduce this protein's level in breast cancer
cells lowered the
cells» ability to migrate away from the tumor site.
Fourteen participating
teams each
engineered two chemotaxis models, the amoeba Dictyostelium discoideum (Dicty), and the human
cell line HL60, to run a millimeter - long maze of interconnected, orthogonal channels designed to mimic the
cell's natural environment.
Interestingly, when the
team stimulated sour
cells with light, they did not observe that kind of aversive behavior in the
engineered mice.
Shah and his
team induced toxin resistance in human neural stem
cells and subsequently
engineered them to produce targeted toxins.
To turn this into something that could one day be a viable therapy for people, the
team took stomach stem
cells from diabetic mice,
engineered them with the same genes and grew mini-organs.
Emotiv solved this brain — computer interface problem with the help of a multidisciplinary
team that included neuroscientists, who understood the brain at a systems level (rather than individual
cells), and computer
engineers with a knack for machine learning and pattern recognition.
A
team led by neuroscientist Khalid Shah, MS, PhD, who recently demonstrated the value of stem
cells loaded with cancer - killing herpes viruses, now has a way to genetically
engineer stem
cells so that they can produce and secrete tumor - killing toxins.
Now a
team of
engineers at MIT has developed a new way to deliver such vaccines directly to the lymph nodes, where huge populations of immune
cells reside: These vaccines hitch a ride to the lymph nodes by latching on to the protein albumin, found in the bloodstream.
Dr. Zhou and his
team genetically
engineered dendritic
cells with a light - sensitive calcium gate - controlling protein.
Even more encouraging, the
engineered tissues still continued to produce human neural, cartilage, and liver
cell proteins, the
team reports online this week in the Proceedings of the National Academy of Sciences.
Zhao's
team, working with bioengineers in Lu's lab, realized that live
cells might also serve as responsive materials for 3D - printed inks, particularly as they can be genetically
engineered to respond to a variety of stimuli.
So when an international
team of
engineers wanted to design tiny robots that could move
cells around, deliver drugs deep inside the body or clean clogged arteries, they looked to nature for inspiration: sperm.
Lu provided the
team with bacterial
cells engineered to light up in response to a variety of chemical stimuli.
A
team of
engineers at MIT has harnessed viruses to make components for a remarkable new kind of battery, half the size of a human
cell and far more efficient than your usual AAA.
The
team now plan to genetically
engineer healthy
cells to produce the same metabolic behaviour.
Using a combination of human or specially
engineered mouse
cells in vitro and in vivo animal models, study senior investigator Judy Lieberman, MD, PhD; study lead investigator Farokh Dotiwala, PhD, with a
team lead by the Brazilian parasitologist Ricardo Gazzinelli, DSc, DVM, found that when an immune killer
cell, such as a T -
cell or natural killer (NK)
cell, encounters a
cell infected with any of three intracellular parasites (Trypanosoma cruzi, Toxoplasma gondii or Leishmania major), it releases three proteins that together kill both the parasite and the infected
cell:
In the phase I / II clinical trial of 20 patients, the
engineered cells were deemed safe, trafficked to the site of the tumor (bone marrow), and persisted in 90 percent of the patients who reached two years follow up after infusion, the research
team found.
Now, as a proof of principle, Chin's
team has
engineered fruit flies that incorporated three new amino acids into proteins in the
cells of their ovaries (Nature Chemical Biology, DOI: 10.1038 / nchembio.1043).
To bypass the challenge, the
team relied on their complementary expertise in genome
engineering, stem
cell differentiation into neurons, and genomic analysis of alternative splicing.
Ngai's group
teamed up with UC Berkeley statisticians and computer scientists — led by Sandrine Dudoit, a professor of biotstatistics and statistics, Elizabeth Purdom, a professor of statistics, and Nir Yosef, a professor of electrical
engineering and computer sciences — to develop a way to analyze the experimental data and identify
cells with similar RNA profiles, indicative of specific
cell types and developmental states.
The
team first tested the antibody in cultured
cells engineered to express the Nav1.7 sodium channel.
To find out, the
team engineered baby hamster kidney
cells to express the human ACE2 receptor.
In an effort to overcome these limitations, a
team at the Wyss Institute for Biologically Inspired Engineering led by its Founding Director, Donald Ingber, M.D., Ph.D., had previously
engineered a microfluidic «Organ - on - a-Chip» (Organ Chip) culture device in which
cells from a human intestinal
cell line originally isolated from a tumor were cultured in one of two parallel running channels, separated by a porous matrix - coated membrane from human blood vessel - derived endothelial
cells in the adjacent channel.
Today, at 56, Atala oversees 300 researchers and support personnel, including chemists, biologists and
engineers divided into different
teams working on
cell therapy, a technology for what he calls partial transplants and the creation of new organs.
By
engineering red blood
cells to have «sticky» proteins on their surface, a
team of researchers has given the
cells the ability to carry anything from drugs to treat immune disorders or cancer to radioactive molecules used in imaging of blood vessels.
The research
team thinks mimicking the approach could yield some new high - strength adhesives — and might even work in tissue
engineering to stick
cells to scaffolds when building artificial organs.
Knowing that Notch governs vessel permeability makes it a candidate for new drugs to treat cardiovascular diseases as well, and the
team is also investigating the TMD as a potential therapeutic agent itself, as
cell models that were exposed to leak - inducing inflammation displayed a dramatic reduction in leakage when they were
engineered to express the TMD.
In a previous study (Applied Physics Letters, Volume 103, Issue 2, 021116 (2013)-RRB- the research
team of David R. Barbero already demonstrated that nano -
engineered networks can be produced onto thin and flexible transparent electrodes that can be used in flexible solar
cells.
After outfitting the nanoparticles with their molecular assistants and
engineering the
cell membranes to receive the nanoparticles, the
team applied a solution of nanoparticles to the
cell cultures and switched on a magnetic field.
Several research
teams had reasoned that if yeast
cells could be
engineered to express mannosidase, the
cells wouldn't produce the mannose - rich sugar complexes that are so immunogenic to humans.
A research
team has come up with a way of genetically
engineering the DNA of mammalian
cells to carry out complex computations, in effect turning the
cells into biocomputers.
When the
team genetically
engineered female mice to be unable to make these NK
cells, the animals had fetuses that were half normal size.